Tomas Xuclà-Ferrarons

Tomas Xuclà-Ferrarons

Auto-generated profile, based on publicly available information

Tomas Xuclà-Ferrarons

Stroke Unit, Department of Neurology, Cerebrovascular Pathology Research Group, University Hospital Doctor Josep Trueta, Institut d'Investigació Biomèdica de Girona (IDIBGI-CERCA), RICORS-ICTUS, Av. França s/n (7a planta), Girona, 17007, Spain

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2025 in Neurology
Verified
Journal Article
Closed access
MGMarina Guasch-Jiménez
Marina Guasch-Jiménez
GDGarbiñe Ezcurra Díaz
Garbiñe Ezcurra Díaz
ÁLÁlvaro Lambea-Gil
Álvaro Lambea-Gil
ARAnna Ramos-Pachón
Anna Ramos-Pachón
AMAlejandro Martinez-Domeño
Alejandro Martinez-Domeño
A(as the Catalan Stroke Code and Reperfusion Consortium (CICAT)
as the Catalan Stroke Code and Reperfusion Consortium (CICAT)
In patients with acute ischemic stroke (AIS), the impact of hemorrhagic transformation (HT) after endovascular treatment (EVT) on poorer stroke outcome is well established when associated with clinical deterioration. However, the influence of asymptomatic HT remains unclear. We aimed to examine the impact of asymptomatic HT after EVT on functional outcome and mortality. Drawing on Catalan (Spain) population-based prospective stroke registry data, we included patients from 10 comprehensive stroke centers with anterior circulation AIS (2017-2023) who underwent EVT, excluding patients without data on the presence of HT or functional outcome at 3 months of follow-up. HT was categorized as parenchymal hemorrhage (PH), hemorrhagic infarct (HI) types 1 and 2, and remote PH (rPH). Asymptomatic HT was defined as any HT not causing death or the NIH Stroke Scale (NIHSS) score to increase by ≥ 4 points. Functional outcome was centrally assessed using the modified Rankin Scale (mRS). The primary end point was a shift in the 3-month mRS score. After excluding symptomatic intracerebral hemorrhage (sICH), multivariable ordinal regression analyses (adjusted by age, mRS, baseline NIHSS score, baseline Alberta Stroke Program Early CT Score, and modified Thrombolysis In Cerebral Infarction score ≥2b) were performed to test for asymptomatic HT association with the primary end point. We included 3,067 patients (72.0 ± 13.6 years, 50.7% women), 179 (5.8%) with sICH and 612 (20.0%) with asymptomatic HT. HT category frequencies were 8.9% HI1, 7.2% HI2, 4.4% PH1, 3.8% PH2, and 1.5% rPH. The percentage of asymptomatic patients showed a hierarchical distribution, ranging from 93.4% in HI1 to 25.0% in PH2. In the multivariable analysis, asymptomatic HT was associated with poorer outcomes (common odds ratio [cOR] 2.24, 95% CI 1.89-2.66) and higher mortality (adjusted odds ratio 1.50, 95% CI 1.17-1.91). In the sensitivity analyses, the association with functional outcome remained significant for each HT category, with asymptomatic PH2 showing the highest odds of poorer outcomes (cOR 3.15, 95% CI 1.46-6.83). In patients with AIS undergoing EVT, asymptomatic HT was associated with poorer functional outcomes and higher mortality, suggesting that any HT, regardless of its clinical impact or radiologic category, should be considered as an additional EVT safety measure.

1 October 2025 in Neurology
Verified
Journal Article
Closed access
GEGarbiñe Ezcurra-Díaz
Garbiñe Ezcurra-Díaz
PCPere Cardona
Pere Cardona
NRNoelia Rodriguez-Villatoro
Noelia Rodriguez-Villatoro
ACAntonio Doncel-Moriano Cubero
Antonio Doncel-Moriano Cubero
BFBelen Flores-Pina
Belen Flores-Pina
PCPol Camps-Renom
Pol Camps-Renom
Management of carotid lesions during endovascular therapy (EVT) in patients with acute ischemic stroke (AIS) due to tandem lesions (TL) remains controversial, and long-term prognosis data are scarce. We evaluated 90-day and 1-year follow-up outcomes of emergent carotid artery stenting (eCAS) vs non-eCAS in these patients. Data from a prospective mandatory population-based registry of Code Stroke in Catalonia (Spain) between 2017 and 2023 were analyzed. Patients with large vessel occlusion and ipsilateral ≥50% atheromatous cervical internal carotid artery (ICA) stenosis undergoing EVT were identified. eCAS and non-eCAS groups were compared. The primary outcome was the shift in the modified Rankin Scale (mRS) score at 90 days and 1 year of follow-up, adjusted using inverse probability of treatment weighting. Stratified analyses in predefined key subgroups according to sex, age, degree of ICA stenosis, Alberta Stroke Program Early CT Score, baseline NIH Stroke Scale, and previous IV thrombolysis were performed. Secondary outcomes included successful recanalization (modified Thrombolysis In Cerebral Infarction ≥2b), 90-day favorable functional outcome (mRS 0-2), hemorrhagic transformation (HT), and 90-day mortality. Among 578 patients included (mean age 70.2 years old, 140 [24.2%] women), 344 patients (59.5%) underwent eCAS. eCAS was associated with a better functional outcome at 90 days (common odds ratio [cOR] for a 1-point less on the mRS score 1.47, 95% CI 1.20-1.82, p < 0.001) and 1 year of follow-up (cOR of 1.47, 95% CI 1.16-1.85, p = 0.001), and with higher successful recanalization rates (OR 4.28, 95% CI 2.61-7.0, p < 0.001), without increasing HT risk or mortality. The benefit of eCAS was consistent in both moderate (50%-69%) and severe (≥70%) ICA stenosis subgroups. Among the eCAS group, patients under dual antiplatelet therapy at 24 hours showed higher rates of favorable functional outcome (54.6% vs 22.9%, p < 0.001). Potential treatment effect differences were observed for women and older patients. In this population-based study of patients with AIS due to TL, eCAS was associated with a better mid-term and long-term functional outcome without safety concerns, even in moderate ICA stenosis. Limitations include the observational design and possible unmeasured confounders. Further studies are needed to explore the mechanisms underlying the differential effects of eCAS in women and older patients. This study provides Class II evidence that in patients with AIS and TL undergoing EVT, eCAS is associated with favorable functional outcome at 90 days compared with EVT alone.

9 January 2023 in Journal of the Peripheral Nervous System
Verified
Journal Article
Closed access
TXTomas Xucla‐Ferrarons
Tomas Xucla‐Ferrarons
JTJanina Turon‐Sans
Janina Turon‐Sans
MCMarta Caballero‐Avila
Marta Caballero‐Avila
ECElena Cortes‐Vicente
Elena Cortes‐Vicente
RRRicard Rojas-Garcia
Ricard Rojas-Garcia

20 July 2026 in Translational Stroke Research
Verified
Journal Article
Open access
MLMaria Lucas-Parra
Maria Lucas-Parra
CGCarme Gubern-Mérida
Carme Gubern-Mérida
SDSofia Dávila
Sofia Dávila
TXTomàs Xuclà-Ferrarons
Tomàs Xuclà-Ferrarons
JMJoan Martínez
Joan Martínez
YSYolanda Silva
Yolanda Silva
Inflammation contributes to haematoma expansion (HE) and poor prognosis in spontaneous intracerebral haemorrhage (ICH). This study aimed to characterise the temporal profile of soluble Toll-like receptor 4 (sTLR4) during the hyperacute and acute phases of ICH and to evaluate its association with HE. Serum sTLR4 levels were measured at admission, 24 and 72 h from 99 patients with primary hemispheric ICH within 12 h of symptom onset, and at baseline from 39 non-stroke controls using enzyme-linked immunosorbent assay (ELISA). Longitudinal sTLR4 fluctuations were evaluated through linear mixed-effects models. Independent HE prognosticators were identified using multivariable logistic regression, and model performance was assessed via the area under the receiver operating characteristic curve (AUC-ROC). ICH patients exhibited significantly higher baseline sTLR4 levels than controls, which declined over time and were not associated with clinical variables. Notably, patients with HE demonstrated higher admission sTLR4 levels than those without HE (2.50 [95% CI: 1.84–3.16] vs. 1.62 [95% CI: 1.22–2.02] ng/mL, p = 0.027). Furthermore, while the non-HE group showed a rapid decrease within the first 24 h, the HE group maintained elevated levels with a more gradual decline. A multivariable model incorporating baseline ICH volume and sTLR4 levels achieved an AUC of 0.829, with positive and negative predictive values of 70.8% and 90.1%, respectively. These findings suggest that TLR4 may be involved in the pathophysiology of HE, and the combination of baseline ICH volume and sTLR4 levels could serve as a useful tool to stratify patients into low- and high-risk groups for HE.

19 August 2026 in Clinical Nutrition
Verified
Journal Article
Closed access
TXTomàs Xuclà-Ferrarons
Tomàs Xuclà-Ferrarons
ILIolanda Lázaro
Iolanda Lázaro
CGCarme Gubern-Mérida
Carme Gubern-Mérida
JMJoan Martínez-Sancho
Joan Martínez-Sancho
WHWilliam S. Harris
William S. Harris
YSYolanda Silva
Yolanda Silva